The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II study of eribulin mesylate in combination with trastuzumab and pertuzumab in patients (pts) with human epidermal growth factor receptor 2-positive (HER2+) metastatic breast cancer (MBC).
 
Ines Maria Vaz Duarte Luis
No Relationships to Disclose
 
Hao Guo
No Relationships to Disclose
 
William Thomas Barry
Consulting or Advisory Role - ARMO BioSciences
Research Funding - Pfizer (Inst)
 
Ian E. Krop
Employment - AMAG Pharmaceuticals (I)
Leadership - AMAG Pharmaceuticals (I)
Stock and Other Ownership Interests - AMAG Pharmaceuticals (I)
Research Funding - Genentech
 
Nikhil Wagle
Stock and Other Ownership Interests - Foundation Medicine
Consulting or Advisory Role - Novartis
Research Funding - Genentech/Roche; Merck; Novartis; Pfizer
 
Alarice Lowe
No Relationships to Disclose
 
Danielle Gore
No Relationships to Disclose
 
Chelsea Andrews
No Relationships to Disclose
 
Wafa Osmani
No Relationships to Disclose
 
Steven J. Isakoff
Consulting or Advisory Role - Abbvie; Merrimack; Myriad Genetics; PharmaMar
Research Funding - Abbvie; Genentech; OncoPep; PharmaMar
Travel, Accommodations, Expenses - Myriad Genetics
 
Nadine M. Tung
Research Funding - Myriad Genetics
Patents, Royalties, Other Intellectual Property - Ambry Genetics (Inst)
 
Eric P. Winer
Consulting or Advisory Role - Genentech/Roche; Leap Therapeutics; Novartis; Verastem
Research Funding - Genentech/Roche (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Genentech/Roche
 
Nancy U. Lin
Consulting or Advisory Role - Novartis
Research Funding - Array BioPharma; Genentech; GlaxoSmithKline; Kadmon; Novartis; Oncothyreon
 
Rachel A. Freedman
Research Funding - Eisai (Inst); Genentech (Inst); Puma Biotechnology (Inst)